Answers are grounded in this paper and cite their sources.
Links immunopeptidome profiling to antifibrotic mechanisms, suggesting new therapies for pulmonary fibrosis.
In a paper recently published in Nature Immunology, Bai et al. provided robust evidence that immunopeptidome profiling could serve as a platform for discovering translatable antifibrotic immunotherapies. The authors showed that overcoming T cell dysfunction through the induction of antigen-specific cytotoxic T lymphocytes represents a potent antifibrotic mechanism. 1
No takes yet. Share an insight, caveat, or question.
Karampitsakos et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: